TEVA PHARMS USA INC FDA Approval ANDA 212152

ANDA 212152

TEVA PHARMS USA INC

FDA Drug Application

Application #212152

Documents

Letter2021-12-20

Application Sponsors

ANDA 212152TEVA PHARMS USA INC

Marketing Status

None (Tentative Approval)001

Application Products

001CAPSULE;ORALEQ 0.25MG BASE0FINGOLIMOD HYDROCHLORIDEFINGOLIMOD HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1TA2020-10-01STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB

CDER Filings

TEVA PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212152
            [companyName] => TEVA PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"FINGOLIMOD","activeIngredients":"FINGOLIMOD","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/01\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-10-01
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.